US Patent 9970001 Methods and compositions for nuclease design
Patent 9970001 was granted and assigned to Sangamo Therapeutics on May, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 5, 2015
Date of Patent
May 15, 2018
Patent Application Number
14731821
Patent Citations Received
Patent Inventor Names
Jeffrey C. Miller
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9970001 Methods and compositions for nuclease design
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
